[PDF][PDF] Comparison of the short-term efficacy of two inductive chemotherapy regimens for locally advanced nasopharyngeal caricinoma: docetaxal plus carboplatin …

X Lu, X Guo, MH Hong, QY Chen, Q Zeng… - Chin J …, 2010 - scholar.archive.org
Chinese Journal of Cancer adenocarcinoma; those aged> 60 or< 18 years; KPS score< 80;
abnormal liver and kidney functions; heart disease or impaired heart function; those who …

Treatment of advanced squamous cell caricinomas of the head and neck with initial combination chemotheraphy prior to surgery and/or radiotheraphy: five-year …

HJ Shaw, LA Price, BT Hill - The Journal of Laryngology & Otology, 1984 - cambridge.org
One hundred and thirty-nine patients with advanced head and neck cancer were treated
with a combination of vincristine, bleomycin, methotrexate with a folinic acid rescue, 5 …

An open, multicenter clinical study on cetuximab combined with intensity modulated radiotherapy (IMRT) plus concurrent chemotherapy in nasopharyngeal carcinoma …

T Lu, C Zhao, C Chen, L Gao, J Lang, J Pan… - Journal of Clinical …, 2010 - ascopubs.org
5577 Background: To evaluate the safety and efficacy of cetuximab combined with IMRT+
concurrent cisplatin chemotherapy in patients with loco-regionally advanced NPC in a …

Cetuximab in combination with chemoradiation after induction chemotherapy of locoregionally advanced nasopharyngeal carcinoma: preliminary results

X He, J Xu, W Guo, X Jiang, X Wang, D Zong - Future oncology, 2013 - Taylor & Francis
Aim: This article aimed to determine treatment compliance, acute toxicities and the short-
term curative effects of combining cetuximab with chemoradiation following induction …

An open-labeled, multicentric clinical study of cetuximab combined with intensity-modulated radiotherapy (IMRT) plus concurrent chemotherapy in locoregionally …

C Chen, C Zhao, L Gao, J Lang, J Pan, C Hu, F Jin… - 2012 - ascopubs.org
5535 Background: To evaluate the safety and efficacy outcomes of concurrent cetuximab
plus IMRT and cisplatin in Chinese patients with LA NPC. Methods: Patients with primary …

Combining cetuximab with chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma: a propensity score analysis

WX Xia, H Liang, X Lv, L Wang, CN Qian, YF Ye, LR Ke… - Oral Oncology, 2017 - Elsevier
Objective To compare the effectiveness of concurrent cisplatin chemoradiotherapy plus
cetuximab with that of concurrent chemoradiotherapy (CCRT) alone in locoregionally …

Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin+ taxol in locally advanced nasopharyngeal carcinoma

M Airoldi, P Gabriele, AM Gabriele, M Garzaro… - Cancer chemotherapy …, 2011 - Springer
Purpose Aim of this study was the clinical evaluation of carboplatin–taxol combination in a
neoadjuvant and concomitant setting with conventional radiotherapy in loco-regionally …

[HTML][HTML] Phase II study of induction chemotherapy followed by concurrent chemoradiotherapy with raltitrexed and cisplatin in locally advanced nasopharyngeal …

Y Wu, X Wei, Z Yuan, H Xu, Y Li, Y Li, L Hu… - Chinese Journal of …, 2020 - ncbi.nlm.nih.gov
Objective For locally advanced nasopharyngeal carcinoma (LA-NPC) patients, high
incidences of distant metastases and severe treatment related toxicities are the main …

[HTML][HTML] A phase II study of concurrent cetuximab–cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma

BBY Ma, MKM Kam, SF Leung, EP Hui, AD King… - Annals of oncology, 2012 - Elsevier
Background Based on our previous work on the clinical activity of cetuximab in recurrent
nasopharyngeal carcinoma (NPC), we evaluated the feasibility of adding cetuximab to …

Carboplatin plus taxol is an effective third-line regimen in recurrent undifferentiated nasopharyngeal carcinoma

M Airoldi, F Pedani, S Marchionatti… - Tumori …, 2002 - journals.sagepub.com
Background Recurrent undifferentiated nasopharyngeal carcinoma is a chemosensitive
disease. Few third-line treatments have been reported. Methods Twelve patients (9 males, 3 …